Associate General Counsel, Regulatory Law and Policy | Head, U.S. Regulatory Pol, Teva Pharmaceutical Industries Ltd., United States
Rachel Turow is Associate General Counsel, Regulatory Law & Policy at Teva Pharmaceuticals and Head, U.S. Regulatory Policy. In this role, Rachel provides regulatory legal support to Teva’s specialty and generic pharmaceutical businesses, and supports Teva’s drug-device combination...
Read More →
Regulatory Counsel, Office of Generic Drug Policy, FDA, United States
Lisa Bercu is a regulatory counsel in the Office of Generic Drug Policy, Office of Generic Drugs (OGD) where she focuses on policy development for combination products. Before joining OGD in October 2016, Ms. Bercu worked at a medical society providing strategic advice on issues including...
Read More →
Director, Office of Policy for Pharmaceutical Quality, OPQ, CDER, FDA, United States
Ashley serves as Director of the Office of Policy for Pharmaceutical Quality in the Center for Drug Evaluation and Research at FDA. OPPQ is responsible for developing and clearly communicating science- and risk-based policies and standards related to drug product quality, including...
Read More →
Associate Director for Clinical Affairs, Office of Generic Drugs, CDER, FDA, United States
Dr. William Chong is an Internist and Endocrinologist who has worked at FDA since 2012. He is currently the Associate Director for Clinical Affairs in the Office of Generic Drugs and lends support to the generic drugs program across an array of activities in order to provide safe...
Read More →
Director, Office of Lifecycle Drug Products, OPQ, CDER, FDA, United States
Dr. Susan Rosencrance presently heads FDA's Office of Lifecycle Drug Products within the Office of Pharmaceutical Quality (OPQ). She provides executive leadership by overseeing and directing scientific review programs and activities related to evaluating drug product quality throughout...
Read More →
Office Director, OPMA, OPQ, CDER, FDA, United States
Dr. Stelios Tsinontides is Director of the Office of Pharmaceutical Manufacturing Assessment (OPMA). OPMA evaluates facilities, process design, and control strategies to assess capabilities of manufacturers to produce quality pharmaceutical and biotechnology products at commercial...
Read More →LZ
Deputy Director, Office of Research & Standards, Office of Generic Drugs, CDER, FDA, United States
Dr. Lei Zhang is Deputy Director of the Office of Research and Standards within the Office of Generic Drugs in CDER, FDA. She is an accomplished professional with more than 22 years of combined experiences in the areas of drug research, development and regulatory review and approval...
Read More → 
